Commentary: Outcomes of Surgical Aortic Valve or Root Replacement in Patients on Hemodialysis: Lessons Learned and Remaining Challenges

End-stage renal disease (ESRD) patients undergoing hemodialysis (HD) are at high-risk when undergoing surgical aortic valve replacement (SAVR). After SAVR, the cardiovascular disease and renal comorbidities in these HD patients increase the risk of 30-day mortality by up to 15-17%, approximately 40% at 3 years, and 60% at 5 years.1 –3 Thus, it is essential to carefully assess preoperative comorbidities of each patient and to optimize prosthetic valve selection and surgical procedure. This will minimize the deleterious effect of cardiopulmonary bypass (CPB) and HD-associated postoperative morbidities and increase survival and quality of life.

Source: Seminars in Thoracic and Cardiovascular Surgery - July 25, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Ko Bando Tags: ADULT – Commentary Source Type: research